Skip to content

Bausch Health Companies Inc.

BHC· NYSECore metricsCIK 885590

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -1.08%
Market cap
$3.09B
374.27M shares
Filings
1,038
$2.94B
Q3 2026+6.7% FY25 yoy
$436.00M
Q3 2026N/M FY25 yoy
$983.00M
Q3 2026+17.3% FY25 yoy
$1.46B
Q3 2026derived−20.4% FY25 yoy
$1.15
Q3 2026N/M FY25 yoy
$2.49B
Q3 2026+10.8% FY25 yoy
$3.09B
—
0.3×
—
60.33%
—

Twelve months to Sep 30, 2026 · derived

Price

$8.26+21.29%+$1.45past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$10.27BFY 2025
$10.45B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$10,266,000,000reported
FY 20242024-12-31$9,625,000,000reported
FY 20232023-12-31$8,757,000,000reported
FY 20222022-12-31$8,124,000,000reported
FY 20212021-12-31$8,434,000,000reported
FY 20202020-12-31$8,027,000,000reported
FY 20192019-12-31$8,601,000,000reported
FY 20182018-12-31$8,380,000,000reported
FY 20172017-12-31$8,724,000,000reported
FY 20162016-12-31$9,674,000,000reported
FY 20152015-12-31$10,447,000,000reported
FY 20142014-12-31$8,206,000,000 revisedreported

Capital returns

Dividends and buybacks · FY2008 to FY2017
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2017—$0.00$0.00—348.84M sh+0.3%0.0%
FY2016—$0.00$0.00—347.84M sh+1.4%0.0%
FY2015—$72.00M$72.00M—343.02M sh+2.0%3.6%
FY2014—$0.00$0.00—336.20M sh+0.4%0.0%
FY2013—$55.60M$55.60M—334.87M sh+9.5%6.0%

Segments

Revenue by Segments, FY2018 to FY2025FY2018Salix · FY2018 · $1.75BBaush and Lomb/International Segment · FY2018 · $4.66BDiversified Products · FY2018 · $1.35BOrtho Dermatologics · FY2018 · $617.00MFY2019Bausch + Lomb · FY2019 · $3.78BSalix · FY2019 · $2.02BInternational · FY2019 · $1.15BBaush and Lomb/International Segment · FY2019 · $4.74BDiversified Products · FY2019 · $1.09BOrtho Dermatologics · FY2019 · $560.00MFY2020Bausch + Lomb · FY2020 · $3.42BSalix · FY2020 · $1.90BInternational · FY2020 · $1.18BSolta Medical · FY2020 · $253.00MBaush and Lomb/International Segment · FY2020 · $4.41BDiversified Products · FY2020 · $1.27BOrtho Dermatologics · FY2020 · $548.00MFY2021Bausch + Lomb · FY2021 · $3.77BSalix · FY2021 · $2.07BInternational · FY2021 · $1.17BDiversified · FY2021 · $1.12BSolta Medical · FY2021 · $308.00MDiversified Products · FY2021 · $1.12BOrtho Dermatologics · FY2021 · $564.00MFY2022Bausch + Lomb · FY2022 · $3.77BSalix · FY2022 · $2.09BInternational · FY2022 · $988.00MDiversified · FY2022 · $978.00MSolta Medical · FY2022 · $300.00MDiversified Products · FY2022 · $978.00MFY2023Bausch + Lomb · FY2023 · $4.15BSalix · FY2023 · $2.25BInternational · FY2023 · $1.07BDiversified · FY2023 · $943.00MSolta Medical · FY2023 · $347.00MFY2024Bausch + Lomb · FY2024 · $4.79BSalix · FY2024 · $2.33BInternational · FY2024 · $1.11BDiversified · FY2024 · $950.00MSolta Medical · FY2024 · $440.00MFY2025Bausch + Lomb · FY2025 · $5.10BSalix · FY2025 · $2.58BInternational · FY2025 · $1.13BDiversified · FY2025 · $937.00MSolta Medical · FY2025 · $518.00M
LineFY2025ShareChange
Bausch + Lomb$5.10B50%+6.5%
Salix$2.58B25%+10.5%
International$1.13B11%+1.9%
Diversified$937.00M9.1%−1.4%
Solta Medical$518.00M5.0%+17.7%
Baush and Lomb/International Segment———
Diversified Products———
Ortho Dermatologics———
Total$10.27B

From the 10-K filed Feb 19, 2026BHC

Pharmaceutical preparations

Bausch Health Companies Inc. is the 14th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR